Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Williams

Showing results (191-200 of 417) with videos related to

Pageof 42
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 24, 2019
Impact of Changes to National Hypertension Guidelines on Hypertension Management and Outcomes in the United KingdomSarah L Lay-Flurrie, James P Sheppard, Richard J Stevens, et al.
The Journal of Infection|March 15, 2021
Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rateZain Chaudhry, Marianne Shawe-Taylor, Tommy Rampling, et al.
Diabetologia|September 18, 2014
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesSophia Zoungas, Mark Woodward, Qiang Li, et al.
BMC Cardiovascular Disorders|February 18, 2009
Protocol for a randomised controlled trial of telemonitoring and self-management in the control of hypertension: telemonitoring and self-management in hypertension. [ISRCTN17585681]Richard J McManus, Emma P Bray, Jonathan Mant, et al.
Hypertension (Dallas, Tex. : 1979)|February 27, 2026
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and MortalityLucas Lauder, Igor Schwantke, Alejandro de la Sierra, et al.
Diabetes Care|June 1, 2014
Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trialPaul Welsh, Mark Woodward, Graham S Hillis, et al.
BMJ Medicine|June 24, 2025
Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort studyVincent Ka Chun Yan, Chengsheng Ju, Thomas MacLennan MacDonald, et al.
BMJ Open|August 9, 2015
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertensionMorris J Brown, Bryan Williams, Thomas M MacDonald, et al.
JACC. Cardiovascular Interventions|February 11, 2022
Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification: 3-Year Results From the CALM-FIM StudyMonique E A M van Kleef, Chandan M Devireddy, Jan van der Heyden, et al.
Journal of Hypertension|June 10, 2009
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial studyPeter Sleight, Josep Redon, Paolo Verdecchia, et al.
Pageof 42

Showing results (191-200 of 417) with videos related to

Sort By:
Pageof 42
Hypertension (Dallas, Tex. : 1979)|December 24, 2019
Impact of Changes to National Hypertension Guidelines on Hypertension Management and Outcomes in the United KingdomSarah L Lay-Flurrie, James P Sheppard, Richard J Stevens, et al.
The Journal of Infection|March 15, 2021
Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rateZain Chaudhry, Marianne Shawe-Taylor, Tommy Rampling, et al.
Diabetologia|September 18, 2014
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesSophia Zoungas, Mark Woodward, Qiang Li, et al.
BMC Cardiovascular Disorders|February 18, 2009
Protocol for a randomised controlled trial of telemonitoring and self-management in the control of hypertension: telemonitoring and self-management in hypertension. [ISRCTN17585681]Richard J McManus, Emma P Bray, Jonathan Mant, et al.
Hypertension (Dallas, Tex. : 1979)|February 27, 2026
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and MortalityLucas Lauder, Igor Schwantke, Alejandro de la Sierra, et al.
Diabetes Care|June 1, 2014
Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trialPaul Welsh, Mark Woodward, Graham S Hillis, et al.
BMJ Medicine|June 24, 2025
Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort studyVincent Ka Chun Yan, Chengsheng Ju, Thomas MacLennan MacDonald, et al.
BMJ Open|August 9, 2015
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertensionMorris J Brown, Bryan Williams, Thomas M MacDonald, et al.
JACC. Cardiovascular Interventions|February 11, 2022
Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification: 3-Year Results From the CALM-FIM StudyMonique E A M van Kleef, Chandan M Devireddy, Jan van der Heyden, et al.
Journal of Hypertension|June 10, 2009
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial studyPeter Sleight, Josep Redon, Paolo Verdecchia, et al.
Pageof 42